ZNRF3 and adrenal cortex carcinoma: A similar explanation may also apply to ZNRF3-mutant cancers of the endometrium and liver that also often show co-occurrence with other β-catenin activating mutations (Supplementary Table 1), while in other cancers such as melanomas and adrenocortical carcinomas the ZNRF3 mutation may be sufficient in itself.